Arm Holdings (ARM -0.30%) has long stood out in the semiconductor industry, particularly regarding its mobile phone processors. Instead of manufacturing these processors, it earns revenue by licensing its designs to companies such as Samsung, Apple, and Qualcomm.Despite its importance to major industry players, it did not launch its initial public offering (IPO) until September 2023, and its value has nearly tripled since the original IPO price. Amid those gains, investors may wonder whether the stock will ...

Investors looking for solid income stocks to boost their passive income can find some attractive opportunities in 2025. The past few years have seen high inflation and interest rates put pressure on the financial results and share prices of top consumer brands. This has driven the dividend yield up to attractive levels for several top companies.To give you some ideas, three Fool.com contributors believe Target (TGT -0.22%), Starbucks (SBUX 0.60%), and Philip Morris (PM -0.28%) are solid buys today. Here's w ...

High Income DIY Portfolios: The primary goal of "High Income DIY Portfolios" Marketplace service is high income with low risk and preservation of capital. It provides DIY investors with vital information and portfolio/asset allocation strategies to help create stable, long-term passive income with sustainable yields. The portfolios are designed for Income-Investors (including retirees or near-retirees). We provide seven portfolios: 3 buy-and-hold, 3 Rotational portfolios, and 3-Bucket NPP Model Portfolio. T ...

Microsoft’s carbon footprint is huge. It thinks storing human waste underground might help solve that problem. https://t.co/9JwSqTyOD1 ...

New Survey: Wealthy Investors Shift Focus From Long-Term Impact To Immediate Gains https://t.co/9r896MWHOU https://t.co/3bV8gH8D4l ...

Alphabet (GOOG 0.66%) (GOOGL 0.78%) is scheduled to release a massive update that could have enormous implications for stock market investors.*Stock prices used were the afternoon prices of July 12, 2025. The video was published on July 14, 2025. ...

Core Viewpoint - Viking Therapeutics has experienced significant stock volatility, with shares down nearly 60% since October of last year and 68% from early 2024 highs, despite a promising drug pipeline [1][2][3] Company Overview - Viking Therapeutics is a pre-revenue biopharma company with a market cap of $3.5 billion, focusing on developing treatments for rare metabolic and endocrine disorders [3][4] - The company is currently testing four different drugs across five clinical trials, with its lead candidate VK2735, an injectable anti-obesity drug, in phase 3 testing [4][5] Market Dynamics - The stock's volatility is attributed to market reactions to the drug's development progress, with investors often overreacting to news, leading to sharp price fluctuations [7][8] - Historical patterns in biopharma stocks suggest that significant price drops can precede a recovery, especially when the underlying drug shows potential [2][14] Competitive Landscape - Viking's VK2735 competes with established obesity drugs from Novo Nordisk and Eli Lilly, but there is potential for market share due to consumer willingness to try alternatives [15][16] - The global weight-loss drug market is projected to grow from $15 billion to $150 billion by 2035, indicating substantial growth opportunities for Viking Therapeutics [16] Future Outlook - The stock is expected to rally within a two-year timeframe as meaningful updates on VK2735's phase 3 testing are anticipated [17] - Concerns regarding the cost of manufacturing VK2735 in both injectable and oral forms may be overstated, given the projected demand in the market [18]

Core Insights - YieldMax funds are recognized for their potential to provide significant dividend yields that can be transformative for investors under favorable conditions [1] - The investment strategy involves a combination of classic dividend growth stocks, Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds like the S&P [1] Investment Strategy - The approach taken by the company is to create a hybrid system that balances growth and income, allowing for a robust investment income stream [1] - The focus is on uncovering high-quality dividend stocks and other assets that offer long-term growth potential, which can significantly contribute to bill-paying capabilities [1]

Real estate investment trusts (REITs) often make great dividend stocks. They tend to generate stable rental income, which enables them to pay attractive dividends and invest in expanding their portfolios. Those growth investments often allow REITs to steadily increase their dividend payments. Simon Property Group (SPG -0.05%) and Federal Realty Investment Trust (FRT -0.53%) are two of the largest REITs focused on the retail sector. Both pay attractive and growing dividends. However, investors are likely to ...

Group 1 - The article discusses the benefits of subscribing to Beyond the Wall Investing, highlighting potential savings on equity research reports from banks [1] - It mentions a bullish outlook on Salesforce (NYSE: CRM), emphasizing stable margins despite moderating growth rates [1] - The investing group offers features such as a fundamentals-based portfolio, weekly analysis from institutional investors, and alerts for short-term trade ideas [1] Group 2 - The article indicates that the analyst may initiate a long position in CRM within the next 72 hours, suggesting a potential investment opportunity [1]